Mycosis fungoides: cutaneous T-cell lymphoma
- PMID: 2021105
Mycosis fungoides: cutaneous T-cell lymphoma
Erratum in
- Am Fam Physician 1991 Jun;43(6):1954
Abstract
Most patients with mycosis fungoides are between 40 and 60 years of age. The disease has three clinical stages: (1) the premycotic, or patch, stage, consisting of macular, scaling, faint pink to red pruritic patches, usually on unexposed surfaces; (2) the mycotic, or plaque, stage, consisting of reddish, purple-brown plaques, often annular in shape and symmetric in distribution, and (3) the tumor stage, consisting of red-brown to violaceous, dome-shaped, firm tumors with a predilection for the face and body folds. The Sézary syndrome is a leukemic variant. Treatment depends on the extent of disease and includes topical or systemic chemotherapy, radiotherapy and psoralen plus long-wave ultraviolet light therapy.
Similar articles
-
A modified staging classification for cutaneous T-cell lymphoma.J Am Acad Dermatol. 2001 Nov;45(5):700-6. doi: 10.1067/mjd.2001.117722. J Am Acad Dermatol. 2001. PMID: 11606919
-
Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis.Oncology (Williston Park). 2003 Sep;17(9):1281-8. Oncology (Williston Park). 2003. PMID: 14569854 Review.
-
Mycosis fungoides and the Sézary syndrome.Semin Oncol. 1999 Jun;26(3):276-89. Semin Oncol. 1999. PMID: 10375085 Review.
-
Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.Br J Dermatol. 2006 Oct;155(4):756-62. doi: 10.1111/j.1365-2133.2006.07428.x. Br J Dermatol. 2006. PMID: 16965425
-
Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.Arch Dermatol. 2008 Jun;144(6):738-46. doi: 10.1001/archderm.144.6.738. Arch Dermatol. 2008. PMID: 18559762
MeSH terms
LinkOut - more resources
Medical